| Thomas Fong-jen Chang, MD | |
|
111 Michigan Ave Nw, Washington, DC 20010-2916 | |
| (202) 476-3094 | |
| Not Available |
| Full Name | Thomas Fong-jen Chang |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 111 Michigan Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043515430 | NPI | - | NPPES |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program. NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
The amyloid cascade hypothesis of Alzheimer's disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. The hypothesis has been a major driver of AD research for more than 20 years.
› Verified 1 days ago
| Entity Name | Pediatric Specialists Of Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699119818 PECOS PAC ID: 7719110154 Enrollment ID: O20140509000026 |
News Archive
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program. NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
The amyloid cascade hypothesis of Alzheimer's disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. The hypothesis has been a major driver of AD research for more than 20 years.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Fong-jen Chang, MD Po Box 37215, Baltimore, MD 21297-3215 Ph: (202) 476-3094 | Thomas Fong-jen Chang, MD 111 Michigan Ave Nw, Washington, DC 20010-2916 Ph: (202) 476-3094 |
News Archive
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program. NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
The amyloid cascade hypothesis of Alzheimer's disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. The hypothesis has been a major driver of AD research for more than 20 years.
› Verified 1 days ago
Dr. Nikolai Dmitrievich Khromouchkine, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw Fl 7, Washington, DC 20037 Phone: 202-741-2439 Fax: 202-741-2721 | |
Dr. Jennifer Semel-concepcion, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Medstar National Rehabilitation Hospital, 102 Irving Street, Washington, DC 20010 Phone: 202-877-1504 | |
Dr. Eric Wisotzky, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 102 Irving St Nw, Washington, DC 20010 Phone: 202-877-1621 | |
Janaki Kalyanam, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-1411 Fax: 202-865-4724 | |
Dr. Mehul Jagdish Desai, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2141 K St Nw, Suite 600, Washington, DC 20037 Phone: 202-808-8295 Fax: 202-808-8296 | |
Dr. Paul F. Pasquina, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Physical Medicine Rehabilitation, Walter Reed Army Medical Center, 6900 Georgia Ave, Washington, DC 20307 Phone: 202-782-6369 |